- RYAH Group to start trading on Canadian Securities Exchange following a transaction involving a triangular merger
- RYAH Group is digital health care analytics and technology company developing innovative solutions for the plant-based medical industry
- RYAH is poised for growth as the world transitions to remote health at an accelerated pace due to the pandemic
RYAH Group (formerly known as Prime Blockchain Inc.) will start trading on the Canadian Securities Exchange under the ticker symbol “RYAH” today (
https://ibn.fm/Z6gZj). The New York-based digital health care analytics and technology company is focused on the development and commercialization of innovative technology, including software and hardware, for the plant-based medical industry.
The upcoming listing follows the Company’s previously announced closing of a reverse takeover transaction with Potbotics Inc. The transaction included a triangular merger between RYAH Group (formerly Prime Blockchain, Inc.), Potbotics, and a wholly-owned Florida subsidiary of the Company incorporated to complete the transaction (
https://ibn.fm/EhuYh). For companies making a public market debut, traditional IPOs were dominant until 2019, but novel forms of going public stole the limelight in 2020. This includes reverse mergers, a transaction where a private company buys out shares to control the public company. The two entities merge, which effectively makes the private company become public (
https://ibn.fm/vA0wf).
“This is another major step in our journey in transforming patient care through our remote, connected devices and data analytics, to help unearth breakthrough discoveries that will reshape our understanding of plant-based medicines, nutraceuticals and beyond. We continue to live our mission and vision of delivering cutting-edge innovation to advance digital care and to provide shareholder and consumer value in all of our products and services,” said Gregory Wagner, CEO of RYAH Group Inc.
As an emerging company, RYAH Group Inc. has been committed to leveraging its know-how in predictive analytics to establish itself as a leader in delivering innovative, user-friendly IoT devices in the plant-based medical industry. The Company applies novel AI-powered analytics to pioneer a suite of vertically integrated technologies to facilitate data collection across the medical plant lifecycle, offering users added control over their health and wellness.
RYAH Group Inc’s powerful artificial intelligence platform collects and correlates HIPAA-compliant medical data to assist doctors and patients in personalizing therapeutic treatments to better predict treatment outcomes. The data aggregation is also relevant for research institutions, pharmacies, clinics, growers, dispensaries and licensed processors to monitor and manage plant-based medicine and other formulation effects on patients.
RYAH Group Inc’s commitment to advance the transition to remote digital care and data analytics in patient treatments appears to be well-timed. The last year saw the world shifts to everything online — health care included. With so many growth opportunities opened up due to the pandemic, the Company appears poised to solidify its position in the digital health care analytics market with the upcoming listing.
For more information, visit the company’s website at
www.RYAHGroup.com.
NOTE TO INVESTORS: The latest news and updates relating to RYAH Group are available in the company’s newsroom at
https://ibn.fm/RYAH
